Please login to the form below
Bydureon BCise
This page shows the latest Bydureon BCise news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Blincyto another option in ALL alongside Kymriah, AZ approval for Bydureon
The new once-weekly formulation called Bydureon BCise uses a new simpler injection device, and was approved in the US in October. ... Sales of Bydureon shrank 2% in the first half of 2018, thanks to a combination of US pricing pressure and growing
Latest news
-
AZ gets US green light for new Bydureon formulation
Its latest injectable suspension proven to reduce blood sugar levels. AstraZeneca’s newly formulated Bydureon BCise (exenatide extended-release) has received US approval from the Food and Drug Administration (FDA) for ... reduction. Ruud Dobber,
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
-
Vice President
-
Competitive Salary Offered
-
Consultant
-
competitive salary
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Director or Senior Account Director
-
Salary TBC
Subscribe to our email news alerts
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- NantKwest rockets on promising pancreatic cancer data
- Latecomer Lilly preps its IL-23 drug for Crohn’s disease
- Key success factor (KSF)
- Bayer bulks up in women’s health again with non-hormonal contraceptive deal
- Genital herpes vaccine candidate heads for human studies
- How do companies prepare for reimbursement?
- Lucid Group adds more magic to the mix with four new hires
- Communiqué Awards 2020 is now open for entry
- Novo Nordisk gets MACE prevention claim for Ozempic in US
- NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi
- FDA committee rejects Intellipharmaceutics’ opioid drug Aximris
PMHub
Pegasus
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...
Latest intelligence
- How do companies prepare for reimbursement?
- Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
- Integrating electronic health records into clinical trials
- How organisations are working to realise the research potential of EHRs...
- Keeping up the fight against HIV and using the lessons to tackle other threats
- Danny Buckland interviews Gilead’s Mike Elliott...
Quick links
Infographics
